
    
      This is a study 24-week, two arm, double blinded randomized clinical trial to evaluate the
      effects of high-dose vitamin D3 supplementation compared with placebo, on activity disease,
      fatigue and bone mass.

      Sixty JoSLE patients will be randomized to receive placebo or vitamin D3 (50.000 IU/week) for
      24weeks. The patients return to visits in week 12 and week 24 for evaluation. Study will
      record clinical history, drugs in use, disease activity, and bone mass parameters.
    
  